MICHELLE GAMIO: Open Payments
NPI 1164820643 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 32 payments from 15 companies in 2025. Trend: 2023 $429 · 2024 $449 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $84 |
| Novo Nordisk Inc | 4 | $76 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Abbott Laboratories | 1 | $23 |
Products named: OTEZLA, MOUNJARO, Kerendia, Wegovy, ELIQUIS, XIFAXAN, INSPIRE, SAPIEN 3 Ultra RESILIA.
Industry payments across TX — which companies pay providers there.
